A detailed history of Jennison Associates LLC transactions in Glaukos Corp stock. As of the latest transaction made, Jennison Associates LLC holds 6,080 shares of GKOS stock, worth $951,702. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,080
Holding current value
$951,702
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$113.62 - $135.39 $690,809 - $823,171
6,080 New
6,080 $792,000
Q4 2023

Feb 01, 2024

BUY
$59.53 - $85.11 $455,344 - $651,006
7,649 New
7,649 $608,000
Q3 2020

Nov 04, 2020

SELL
$37.23 - $50.97 $7.72 Million - $10.6 Million
-207,310 Closed
0 $0
Q2 2020

Aug 06, 2020

SELL
$28.78 - $46.83 $4.04 Million - $6.57 Million
-140,231 Reduced 40.35%
207,310 $7.97 Million
Q1 2020

May 06, 2020

SELL
$25.53 - $70.14 $5.43 Million - $14.9 Million
-212,603 Reduced 37.96%
347,541 $10.7 Million
Q4 2019

Feb 07, 2020

BUY
$54.18 - $65.64 $12.6 Million - $15.3 Million
233,373 Added 71.42%
560,144 $30.5 Million
Q3 2019

Nov 08, 2019

BUY
$58.58 - $83.91 $2.31 Million - $3.32 Million
39,518 Added 13.76%
326,771 $20.4 Million
Q2 2019

Aug 06, 2019

BUY
$63.59 - $78.71 $1.39 Million - $1.72 Million
21,850 Added 8.23%
287,253 $0
Q1 2019

May 10, 2019

SELL
$50.75 - $80.54 $10.2 Million - $16.1 Million
-200,390 Reduced 43.02%
265,403 $20.8 Million
Q4 2018

Feb 06, 2019

BUY
$52.18 - $67.93 $2.08 Million - $2.71 Million
39,904 Added 9.37%
465,793 $26.2 Million
Q3 2018

Nov 08, 2018

SELL
$38.13 - $68.37 $9.62 Million - $17.2 Million
-252,207 Reduced 37.19%
425,889 $27.6 Million
Q2 2018

Aug 02, 2018

BUY
$27.62 - $44.51 $2.1 Million - $3.38 Million
75,990 Added 12.62%
678,096 $27.6 Million
Q1 2018

Apr 20, 2018

BUY
$26.05 - $34.5 $4.93 Million - $6.53 Million
189,187 Added 45.82%
602,106 $18.6 Million
Q4 2017

Jan 25, 2018

BUY
$24.5 - $36.01 $10.1 Million - $14.9 Million
412,919
412,919 $10.6 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.